Association between β-adrenergic receptor polymorphisms and their G-protein-coupled receptors with body mass index and obesity in women: A report from the NHLBI-sponsored WISE study

International Journal of Obesity

Volumn 29, Issue 7, 2005, Pages 746-754

  Terra, S G ^a   McGorray, S P ^b   Wu, R ^b   McNamara, D M ^c   Cavallari, L H ^a,d   Walker, J R ^e   Wallace, M R ^f   Johnson, B D ^g   Bairey Merz, C N ^h   Sopko, G ⁱ   Pepine, C J ^f   Johnson, J A ^a,f  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b University of Florida ^*  (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e Orchid Cellmark   (United States)

^f UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^h CEDARS SINAI MEDICAL CENTER   (United States)

ⁱ NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

adrenergic receptor; Body mass index; Pharmacogenetics

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; G PROTEIN COUPLED RECEPTOR; GS PROTEIN ALPHA; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY MASS; CASE CONTROL STUDY; DNA POLYMORPHISM; ENERGY METABOLISM; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; ISCHEMIC HEART DISEASE; LIPOLYSIS; MAJOR CLINICAL STUDY; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADIPOSE TISSUE; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; BODY MASS INDEX; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MIDDLE AGED; OBESITY; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, G-PROTEIN-COUPLED;

EID: 21244471908     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802978     Document Type: Article

References (38)

1. Burton BT, Foster WR, Hirsch J, Van Itallie TB. Health implications of obesity: an NIH consensus development conference. Int J Obes Relat Metab Disord 1985; 9: 155-170.
2. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS. Obesity and the risk of heart failure. N Engl J Med 2002; 347: 305-313.
3. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-1638.
4. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath Jr CW. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999; 341: 1097-1105.
5. CDC, National Center for Health Statistics, National Health & Nutrition Examination Survey. Health, United States (Table 70) 2002. Available from URL: http://www.cdc.gov/nchs/products/pubs/pubd/hus/02tables.htm [Accessed 2004 Apr 3].
6. Kushner RF. Medical management of obesity. Semin Gastrointest Dis 2002; 13: 123-132.
7. Stunkard AJ, Harris JR, Pedersen NL, McClearn GE. The body-mass index of twins who have been reared apart. N Engl J Med 1990; 322: 1483-1487.
8. Ravussin E, Bouchard C. Human genomics and obesity: finding appropriate drug targets. Eur J Pharmacol 2000; 410: 131-145.
9. Barbe P, Millet L, Galitzki J, Lafonatan M, Berlan M. In situ assessment of the role of β1-, β2-, and β3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue. Br J Pharmacol 1996; 117: 907-913.
10. 2-adrenoceptor activation in healthy human volunteers. Br J Clin Pharmacol 1993; 35: 35-39.
11. 1-adrenoceptor: identification and rapid screening assay [letter]. Lancet 1999; 353: 897.
12. Rathz DA, Brown KM, Kramer LA, Liggett SB. Amino acid 49 polymorphisms of the human beta1-adrenergic receptor affect agonist-promoted trafficking. J Cardiovasc Pharmacol 2002; 39: 155-160.
13. 2-adrenergic receptor and asthma. Am J Resp Crit Care Med 1997; 156: S156-S162.
14. Lowe Jr WL, Rotimi CN, Luke A, Guo X, Zhu X, Comuzzie AG, Schuh TS, Halbach S, Kotlar TJ, Cooper RS. The beta 3-adrenergic receptor gene and obesity in a population sample of African Americans. Int J Obes Relat Metab Disord 2001; 25: 54-60.
15. Waltman C, Levine MA, Schwindinger WF, Wand GS. Polymorphism of the gene encoding the alpha subunit of the stimulatory G-protein of adenylyl cyclase (GNAS1). Hum Genet 1994; 93: 477-478.
16. Gutersohn A, Naber C, Muller N, Erbel R, Siffert W. G protein β3 subunit 825TT genotype and post-pregnancy weight retenion. Lancet 2000; 355: 1240-1241.
17. 3 subunit 825T allele on adipogenesis and lipolysis in cultured human preadipocytes and adipocytes. Horm Metab Res 2002; 34: 475-480.
18. Large V, Hellström L, Reynisdottir S, Lönnqvist F, Eriksson P, Lannfelt L, Arner P. Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. J Clin Invest 1997; 100: 3005-3013.
19. Drysdale CM, McGraw DW, Stack CB, Stephens JC, Judson RS, Nandabalan K, Arnold K, Ruano G, Liggett SB. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci USA 2000; 97: 10483-10488.
20. Bairey Merz N, Kelsey SF, Pepine CJ, Reichek N, Reis SE, Rogers WJ, Sharaf BL, Sopko G. The Women's Ischemia Syndrome Evaluation (WISE) Study: protocol design, methodology and feasibility report. J Am Coll Cardiol 1999; 33: 1453-1461.
21. Bairey Merz N, Olson M, McGorray S, Pakstis DL, Zell K, Rickens CR, Kelsey SF, Bittner V, Sharaf BL, Sopko G. Physical activity and functional capacity measurement in women: a report from the NHLBI-sponsored WISE study. J Womens Health Gend Based Med 2000; 9: 769-777.
22. Lewontin RC. The interaction of selection and linkage. I. General considerations; heterotic models. Genetics 1964; 49: 49-67.
23. Pritchard JK, Przeworski SJ. Linkage disequilibrium in humans: models and data. Am J Hum Genet 2001; 69: 1-14.
24. World Health Organization. 1997 Obesity, preventing and managing the global epidemic. WHO: Geneva.
25. Fujisawa T, Ikegami H, Kawaguchi Y, Ogihara T. Meta-analysis of the association of Trp64Arg polymorphism of beta-3-adrenergic receptor gene with body mass index. J Clin Endocrin Metab 1998; 83: 2441-2444.
26. Allison DB, Heo M, Faith MS, Pietrobelli A. Meta-analysis of the association of the Tyrp64Arg polymorphism in the beta 3-adrenergic receptor with body mass index. Int J Obes Relat Metab Disord 1998; 22: 559-566.
27. 2-adrenoceptor-mediated thermogenesis and lipid utilization in obese and lean men. J Clin Endocrinol Metab 2001; 86: 2191-2199.
28. 2-adrenergic receptor gene and lipid metabolism during exercise in obese women. Int J Obes Relat Metab Disord 2002; 26: 1434-1441.
29. Ishiyama-Shigemoto S, Yamada K, Yuan X, Ichikawa F, Nonaka K. Association of polymorphisms in the β2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Diabetologia 1999; 42: 98-101.
30. 2-adrenergic receptor gene is not associated with morbid obesity in Austrian women. Int J Obes Relat Metab Disord 2000; 24: 388-390.
31. 2-adrenoceptor gene on obesity in a French population. Int J Obes Relat Metab Disord 2000; 24: 382-387.
32. Moriarty M, Wing RR, Kuller LH, Ferrell RE. Trp64Arg substitution in the beta 3-adrenergic receptor does not relate to body weight in healthy premenopausal women. Int J Obes Relat Metab Disord 1997; 21: 826-829.
33. 3- adrenergic receptor locus in obesity and noninsulin-dependent diabetes among members of Caucasian families with a diabetic sibling pair. J Clin Endocrinol Metab 1996; 81: 4422-4427.
34. 1-adrenoceptor gene (Gly389Arg ADRB1) in Caucasian women. Int J Obes Relat Metab Disord 2002; 26: 633-639.
35. Ellsworth DL, Coady SA, Chen W, Srinivasan SR, Elkasabany A, Gustat J, Boerwinkle E, Berenson GS. Influence of the β2-adrenergic receptor Arg16Gly polymorphism on longitudinal changes in obesity from childhood through young adulthood in a biracial cohort: the Bogalusa Heart Study. Int J Obes Relat Metab Disord 2002; 26: 928-937.
36. Johnson JA, Zineh I, Puckett BJ, McGorray SP, Yarandi HN, Pauly DF. Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol. Clin Pharmacol Ther 2003; 74: 44-52.
37. 2- Adrenoceptor gene polymorphism, body weight, and physical activity. Lancet 1999; 353: 896.
38. 3-adrenergic receptor gene and obesity risk: effect modification by a sedentary lifestyle. Diabetes, Obes Metab 2002; 4: 428-430.